Baseline LDH as a prognostic biomarker of early treatment failure in lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.

Results of an artificial intelligence–based tool to predict financial toxicity early to facilitate early referral to hospital social workers. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers ...

DENVER, April 17, 2025 /PRNewswire/ -- Imidex, a Denver-based leader in artificial intelligence for healthcare, today announced the sale of its FDA-cleared AI algorithm, VisiRad ® XR, along with its ...

A study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with ...